Location History:
- Illkirch-Graffenstaden, FR (1984)
- Plobsheim Illkirch-Graffenstaden FR (1984)
- Strasbourg, FR (1979 - 1986)
- Plobsheim, FR (1985 - 2007)
Company Filing History:
13 out of 455 
4 out of 48 
4 out of 1,200 
Years Active: 1979-2007
Title: The Innovative Contributions of Maurice W. Gittos
Introduction: Maurice W. Gittos, based in Plobsheim, France, has made significant contributions to the field of pharmaceuticals, holding an impressive portfolio of 25 patents. His work primarily focuses on innovations that address various health issues, particularly stress-related disorders and chemotherapy-induced symptoms.
Latest Patents: Among his latest patents, Maurice W. Gittos has developed novel bisulphate salts, specifically targeting the treatment of stress-related affective disorders. The innovation involves bisulphate salts of certain 3-phenyl-3-dimethylaminoalkyl-4,4-dimethylpiperidin-2,6-diones. These compounds have shown to be devoid of weight loss and hepatocyte changes in rats, thus enhancing the efficacy of clinical doses for conditions such as anxiety, depression, and migraine. His preferred compounds include 3(3,5-dimethoxyphenyl)-3-(3-dimethylaminopropyl)-4,4-dimethylpiperidine-2,6-dione bisulphate, and 3(3-methoxyphenyl)-3-(3-dimethylaminopropyl)-4,4-dimethylpiperidine-2,6-dione bisulphate.
Another notable patent involves the development of amide derivatives of certain 2,6-methano-2H-quinolizine-type compounds. This invention focuses on their potential therapeutic applications, including their role in antagonizing serotonin effects at the 5HT3 receptors, as well as their use in treating conditions such as nausea and vomiting induced by chemotherapy, migraine pain, and cognitive disorders.
Career Highlights: Maurice's career has been marked by innovative research and his dedication to improving pharmacological treatments. He has collaborated with leading pharmaceutical firms, including Merrell Dow Pharmaceuticals and Merrell Toraude Et Compagnie, where he applied his expertise in drug development and patenting.
Collaborations: Throughout his professional journey, Maurice W. Gittos has teamed up with notable colleagues, such as Marcel Hibert and John R. Fozard. Their collaboration has led to groundbreaking developments that push the boundaries of existing medical treatments.
Conclusion: Maurice W. Gittos exemplifies the impact of innovative thinking in the pharmaceutical industry. Through his extensive patent portfolio and collaborations with esteemed colleagues, he continues to make strides in developing effective solutions for complex health issues. His contributions not only enhance the understanding of pharmacological sciences but also pave the way for future advancements in medication and treatment therapies.